Cognition Therapeutics (CGTX) Other financing activities (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Other financing activities of $44000.0 for Q1 2026, up 633.33% quarter-over-quarter from $6000.0 in Q4 2025.
Cognition Therapeutics (CGTX) Other financing activities (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Other financing activities for 6 consecutive years, with $44000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $44000.0; the TTM figure through Mar 2026 stood at $67000.0 (changed N/A YoY), while the FY2025 annual figure was $71000.0, down 13.41% from the prior year.
- Other financing activities rose to $44000.0 in Q1 2026 per CGTX's latest filing, from $6000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.3 million in Q3 2022 and bottomed at $6000.0 in Q4 2025.
- Historically, Other financing activities has averaged $240714.3 across 4 years, with a median of $23000.0 in 2022.
- On a YoY basis, Other financing activities climbed as much as 8566.67% in 2022 and fell as far as 91.05% in 2022.
- Cognition Therapeutics' Other financing activities stood at $23000.0 in 2022, then dropped by 26.09% to $17000.0 in 2024, then plunged by 64.71% to $6000.0 in 2025, then surged by 633.33% to $44000.0 in 2026.
- Business Quant data shows CGTX's Other financing activities at $44000.0 in Q1 2026, $6000.0 in Q4 2025, and $17000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | 1.27 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 22,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 303,000.00 |
| Mar 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |